EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Detection of rare carbapenemases in Enterobacterales—comparison of two colorimetric and three CIM-based carbapenemase assays

Lukas Schaffarczyk, Janina Noster iD, Yvonne Stelzer, Janko Sattler, Sören Gatermann, Axel Hamprecht iD

Microbiology Spectrum · 06.02.2024 · 12 (2)

DOI: 10.1128/spectrum.03015-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 06.02.2024. Verfasst von Lukas Schaffarczyk und 5 weiteren Autor:innen. Beteiligte Einrichtung: Klinikum Oldenburg, Institute of Medical Microbiology and Virology, Oldenburg, Germany. Hauptthemen laut MEDLINE: Carbapenems, Gammaproteobacteria. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapid and reliable detection of carbapenemase-producing Enterobacterales (CPE) is crucial for prompt treatment and infection control. Most assays target the primary four enzymes (KPC, OXA-48-like, VIM, and NDM), often missing less common variants (e.g., GES, IMI, OXA-23, and OXA-58). Therefore, assays based on the hydrolysis of carbapenems are recommended in addition to differentiation tests such as PCR or immunochromatographic assays. The aim of this study was to compare the currently Clinical and Laboratory Standards Institute (CLSI)-recommended tests mCIM (modified carbapenem inactivation method) and Carba NP with new colorimetric tests (NitroSpeed-Carba NP) and novel variations of the carbapenem inactivation method (CIM) such as simplified CIM (sCIM) or modified zinc-supplemented CIM (mzCIM). The challenge collection included 205 clinical isolates, 139 CPE vs 66 non-CPE. Among all 205 isolates, the sensitivity/specificity of mCIM was 81.3%/98.5%, Carba NP 76.3%/100%, NitroSpeed-Carba NP 86.3%/78.8%, sCIM 100%/94%, and mzCIM 97.8%/98.5%. For rare carbapenemases ( n = 48), the sensitivity of mzCIM (98.3%) and sCIM (100%) was higher than that of mCIM (60.4%), Carba NP (50%), or NitroSpeed-Carba NP (70.2%). Most indeterminate results occurred for mCIM (14.4%), Carba NP (8.2%), and sCIM (6.3%). The detection of rare carbapenemases remains challenging with the currently recommended assays. The CIM-based tests demonstrated superior sensitivity, with sCIM and mzCIM outperforming the currently recommended mCIM and Carba NP, especially among isolates with weakly hydrolyzing carbapenemases (e.g., OXA-23 and OXA-58). Although colorimetric assays provide more rapid results, laboratories have to be aware of the low sensitivity for rare carbapenemases. Both sCIM and the new mzCIM performed well, are cost-effective, and can easily be implemented in any laboratory. IMPORTANCE Detection of so-called rare carbapenemases (e.g., GES, IMI, OXA-23, and OXA-58) in Enterobacterales is challenging, and data on the performance of currently available assays are scarce. This study systematically assessed the performance of currently recommended and novel hydrolysis-based assays on a set of molecularly characterized isolates. It demonstrates that the currently recommended assays mCIM and Carba NP perform well on isolates producing common carbapenemases such as KPC, VIM, NDM, and OXA-48, but have only a moderate sensitivity in the detection of rare carbapenemases. In contrast, the newer CIM-based variants, sCIM and mzCIM, are equally capable of detecting frequent and uncommon carbapenemases. These assays could potentially help to improve our knowledge on the epidemiology of these “rare” enzymes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarbapenemsGammaproteobacteriaEnterobacteriaceaeColorimetryMicrobial Sensitivity Testsbeta-LactamasesBacterial ProteinsAnti-Bacterial Agents

Stichwörter der Autor:innen

CPEGESGIMIMIKPCNDMOXA-23OXA-48OXA-58carbapenemase

Substanzen

carbapenemaseCarbapenemsbeta-LactamasesBacterial ProteinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Klinikum Oldenburg, Institute of Medical Microbiology and Virology, Oldenburg, Germany.
  • Carl von Ossietzky University Oldenburg, Institute of Medical Microbiology and Virology, Oldenburg, Germany.
  • Institute for Medical Microbiology, Immunology and Hygiene, University Hospital of Cologne, Cologne, Germany.
  • Department of Medical Microbiology, Ruhr University Bochum, Bochum, Germany.

ORCID-Profile: Janina Noster, Axel Hamprecht

Zitieren

APA

Schaffarczyk, L., Noster, J., Stelzer, Y., Sattler, J., Gatermann, S., & Hamprecht, A. (2024). Detection of rare carbapenemases in Enterobacterales—comparison of two colorimetric and three CIM-based carbapenemase assays. Microbiology Spectrum, 12(2). https://doi.org/10.1128/spectrum.03015-23

Vancouver

Schaffarczyk L, Noster J, Stelzer Y, Sattler J, Gatermann S, Hamprecht A. Detection of rare carbapenemases in Enterobacterales—comparison of two colorimetric and three CIM-based carbapenemase assays. Microbiology Spectrum. 2024;12(2). doi:10.1128/spectrum.03015-23

BibTeX
@article{Schaffarczyk2024,
  author = {Schaffarczyk, Lukas and Noster, Janina and Stelzer, Yvonne and Sattler, Janko and Gatermann, Sören and Hamprecht, Axel},
  title = {Detection of rare carbapenemases in Enterobacterales—comparison of two colorimetric and three CIM-based carbapenemase assays},
  journal = {Microbiology Spectrum},
  year = {2024},
  volume = {12},
  number = {2},
  doi = {10.1128/spectrum.03015-23}
}
Kostenlos starten →